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Establishment of oligodendrocyte identity is crucial
for subsequent events of myelination in the CNS.
Here, we demonstrate that activation of ATP-
dependent SWI/SNF chromatin-remodeling enzyme
Smarca4/Brg1at thedifferentiationonset is necessary
and sufficient to initiate and promote oligodendrocyte
lineage progression and maturation. Genome-wide
multistage studies by ChIP-seq reveal that oligoden-
drocyte-lineage determination factor Olig2 functions
as a prepatterning factor to direct Smarca4/Brg1 to
oligodendrocyte-specific enhancers. Recruitment of
Smarca4/Brg1 todistinct subsets ofmyelination regu-
latory genes is developmentally regulated. Functional
analyses of Smarca4/Brg1 and Olig2 co-occupancy
relative to chromatin epigenetic marking uncover
stage-specific cis-regulatory elements that predict
sets of transcriptional regulators controlling oligoden-
drocyte differentiation. Together, our results demon-
strate that regulation of the functional specificity and
activity of a Smarca4/Brg1-dependent chromatin-
remodeling complex by Olig2, coupled with transcrip-
tionally linked chromatin modifications, is critical to
precisely initiate and establish the transcriptional
program that promotes oligodendrocyte differentia-
tion and subsequent myelination of the CNS.INTRODUCTION
Oligodendrocyte, the specialized cell type for myelination in the
CNS, plays an important role in brain development and neuronal248 Cell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc.function. Its development comprises a stepwise process
including commitment of oligodendrocyte precursor cells
(OPCs) frommultipotent neural progenitors and OPC differentia-
tion into immature and mature myelinating oligodendrocytes
(Pfeiffer et al., 1993). Failure of remyelination by oligodendro-
cytes due to injury or disease impairs rapid propagation of action
potentials and leads to nerve degeneration, and is associated
with demyelinating disorders such as multiple sclerosis (MS)
and leukodystrophies (Berger et al., 2001; Trapp et al., 1998).
The observation that OPCs are present within demyelinating
MS lesions, but fail to differentiate into myelinating cells,
suggests that induction of OPC differentiation is a critical event
for successful remyelination (Chang et al., 2002; Franklin and
Ffrench-Constant, 2008).
How then is the transcriptional program responsible for
precisely initiating oligodendrocyte differentiation in a temporally
specific manner? Oligodendrocyte development depends on
stage-specific transcription factors, including Olig2, Sox10,
YY1, Olig1, MRF, and Zfp191, as well as small noncoding
RNAs such as miR-219 (Emery, 2010; Li et al., 2009). For
instance, the basic-helix-loop-helix (bHLH) transcription factor
Olig2 functions as an oligodendrocyte lineage determination
factor by controlling OPC specification, differentiation, andmye-
lination (Lu et al., 2002; Yue et al., 2006; Zhou and Anderson,
2002). However, whether this list is complete and how these
factors work remain unclear because very few oligodendro-
cyte-specific cis-regulatory elements have been identified and
functionally dissected to fully elucidate the control of their target
gene expression. Identification of lineage-specific cis-regulatory
elements, in conjunction with the cognate transcription factors
that also change at crucial transitions of differentiation, would
help to narrow the search for the key regulators of oligodendro-
cyte development.
Differentiation from OPCs to mature oligodendrocytes (mOLs)
was shown to undergo rapid and substantial nuclear and
chromatin reorganization (Nielsen et al., 2002), suggesting that
chromatin reorganization is crucial for the onset of differentia-
tion. There are two major classes of enzymes that remodel chro-
matin: enzymes that covalently modify histones, and enzymes of
ATP-dependent-remodeling complexes (Becker and Ho¨rz,
2002; Haberland et al., 2009; Jenuwein and Allis, 2001). For
instance, mammalian SWI/SNF-like Brg1/Brm-associated factor
(BAF) chromatin-remodeling complexes are able to use energy
derived from ATP hydrolysis to alter chromatin structures and
regulate nuclear processes such as transcription (Wu et al.,
2009; Yoo and Crabtree, 2009). At present, however, the role
and functional specificity of chromatin-remodeling enzymes
during CNS myelination remain elusive.
To investigate gene activation events during the onset and
progression of OPC differentiation, we performed whole-
genome chromatin immunoprecipitation sequencing (ChIP-
seq) to map the global gene transcripts that are targeted and
activated by RNA polymerase II (RNAPII) at different stages.
We identified that the Smarca4/Brg1 gene, encoding the central
catalytic ATPase subunit of the SWI/SNF chromatin-remodeling
complex, is most significantly targeted by RNAPII at the onset of
OL differentiation. Remarkably, we found that the Brg1 chro-
matin remodeler is transcriptionally prepatterned by Olig2 to
achieve the target-binding specificity and is both necessary
and sufficient to activate expression of myelination-associated
genes and oligodendrocyte lineage progression. In coupling
with epigenetic histone mark signatures, Brg1 and Olig2 co-
occupancy further predicts and reveals lineage-specific
enhancer elements and critical regulators for oligodendrocyte
differentiation at a genome-wide level. Our studies uncover
a dynamic transformation in transcription and epigenetic
marking that occurs during oligodendrocyte lineage progres-
sion, provide a genome-wide view of oligodendrocyte develop-
ment in unusually fine resolution, and unmask an unanticipated
mechanism wherein activation of ATP-dependent chromatin-
remodeling complexes and regulation of Brg1 functional speci-
ficity by Olig2 coupled with transcriptionally linked chromatin
modifications are critical steps to precisely initiate and establish
the transcriptional program for promoting oligodendrocyte
differentiation.
RESULTS
Genome-wide Mapping of RNAPII Targeting Reveals
Activation of Smarca4/Brg1 at the Onset of
Oligodendrocyte Differentiation
To identify the genes that are activated during the transition of
OPC differentiation, we performed ChIP-seq to determine
genome-wide RNAPII-binding targets at different phases of
differentiation. RNAPII occupancy throughout the entire gene
body provides a direct readout of transcriptional activity, partic-
ularly for genes rapidly responding to developmental and
extrinsic cues, and thus yields insights beyond what is typically
achieved by mRNA expression profiling (Adelman and Lis,
2012; Hah et al., 2011). OPCs isolated from neonatal rats were
cultured in differentiation medium (Chen et al., 2007) for 1 day
to initiate theOPCdifferentiation process (Figure 1A). Expression
of the early differentiation marker Cnp increased significantlywith modest expression of mature myelin genes such as Mag,
Mbp, and Plp. The cells at this differentiation initiation stage
were designated as immature oligodendrocytes (iOLs). In
contrast, 4 days after treatment, the cells robustly expressed
myelin genes including Mbp, Plp, Mag, and Cnp and became
mOLs (Figures 1A and 1B).
By analyzing RNAPII targeting in OPCs and iOLs, we observed
a significant enrichment of target genes linked to chromatin-re-
modeling activities during the transition from OPCs to iOLs,
including nucleosome assembly, positioning, and chromatin
reorganization (Figure 1C; Tables S1 and S2 available online).
These data suggest that the initiation of oligodendroglial differ-
entiation involves extensive chromatin remodeling and reorgani-
zation of the transcriptional machinery.
Strikingly, the most prominent and significant RNAPII-binding
target in iOL cells determined by p value and FDR (false
discovery rate <0.05) were mapped to the Smarca4/Brg1 locus,
including intragenic exons and 30 UTRs (Figure 1D). An extensive
and significant enrichment of RNAPII occupancy or pausing on
the Brg1 gene body across mainly the exons was detected in
iOLs over OPCs (Figure 1D). Brg1 was actively transcribed and
upregulated in iOL cells in response to differentiation cues
(Figures 1D and 1E), consistent with the notion that RNAPII
enrichment and accumulation throughout the gene body facili-
tate rapid or synchronous activation of gene expression in
response to signaling cues (Adelman and Lis, 2012). Further
analysis of the binding targets found that RNAPII targeting on
the locus of other SWI/SNF complex subunits including
BAF45b, BAF45d, BAF250b, and BAF60a (Wu et al., 2009) also
increased from OPCs to iOLs (Figure 1D). Because RNAPII
ChIP-seq could capture both actively transcribed and paused
genes, we then performed quantitative real-time PCR and
western blot analysis to confirm upregulation of RNAPII-targeted
Brg1 SWI/SNF complex components during OPC to iOL transi-
tion (Figures 1E and 1G). These findings indicate that expression
of the SWI/SNF-remodeling complex is activated at the onset of
oligodendrocyte differentiation. In contrast, RNAPII occupancy
on the locus of Brm1, the only homolog of Brg1 ATPase, was
comparable between iOLs and OPCs (Figure 1F). Such
a phenomenon of Brg1 activation was not observed in other
cell types, including the change from mouse embryonic stem
cells (ESCs) to embryonic fibroblasts (Min et al., 2011), or
neurons in response to neuronal activity (Kim et al., 2010), or
human breast cancer cells (MCF) in response to estrogen (Hah
et al., 2011) (Figure S1). These observations suggest that activa-
tion of the Brg1 chromatin-remodeling complex is a unique event
to initiate the critical transition of OPC differentiation.
Brg1 Is Required and Sufficient for the Initiation of OPC
Differentiation and Maturation
To determine the developmental state of Brg1+ cells in the oligo-
dendrocyte lineage, we colabeled Brg1 with the stage-specific
markers for differentiated oligodendrocytes (CC1+) or their
precursors (PDGFRa+) in the spinal cord. Brg1 was strongly ex-
pressed in CC1+ differentiated oligodendrocytes but weakly in
PDGFRa+ OPCs (Figures 2A, 2B, and S2). The proportions of
CC1+ among Brg1+ cells in the spinal white matter at P7
and P21 are 74% ± 3.5% and 83.0% ± 4.0%, respectivelyCell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc. 249
Figure 1. The Brg1 Gene Locus Is Most Abundantly Targeted by RNAPII at the Onset of OPC Differentiation
(A) Schematic overview of oligodendrocyte lineage progression.
(B) Expression of Mag, Cnp, Plp, and Mbp in OPC, iOL, and mOL assayed by quantitative real-time PCR (n = 3).
(C) GO analysis of biological processes of RNAPII-targeted genes in iOL.
(D) RNAPII binding on the gene loci of Brg1 and other BAF subunits in OPCs and iOLs.
(E) Expression of Brg1, BAF45b, BAF45d, and BAF60a was assayed in OPCs and iOLs by quantitative real-time PCR (nR 3 independent experiments). *p < 0.05,
* *p < 0.01; Student’s t test.
(F) RNAPII-binding distribution at the Brm1 locus.
(G) Western blot analysis of Brg1, BAF45b, BAF45d, and BAF60a. Histograms show fold changes measured by densitometry in iOLs over OPCs after
normalization with GAPDH (n = 3 experiments).
Data are presented as mean ± SEM. See also Figure S1, and Tables S1 and S2.(>500 cell count; n = 3), suggesting that Brg1 is largely confined
to differentiating cells in the oligodendrocyte lineage.
To assess the functional role of Brg1 in oligodendrocyte devel-
opment in vivo, we ablated Brg1 expression in the oligodendro-
cyte lineage directed by Olig1-Cre (Xin et al., 2005; Ye et al.,
2009) in Brg1 conditional knockout mice (Sumi-Ichinose et al.,
1997) (Figure S2B). We observed that all resulting mutant
Brg1flox/flox;Olig1Cre+/ mice (referred to as Brg1cKO), but not
their control littermates, developed myelin-deficient phenotypes
including generalized tremors, hindlimb paralysis, and seizures
beginning at postnatal week 2. The mice died at postnatal250 Cell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc.week 3–4 in contrast to the normal life span of wild-type and
heterozygotes (Brg1flox/+;Olig1Cre+/). The myelinating optic
nerve tract from Brg1cKO mice at P14 was translucent (Fig-
ure 2C). In addition, expression of myelin genes such as Mbp
(myelin basic protein) and Plp1 (proteolipid protein) was dimin-
ished in the spinal cord and forebrain of mutant mice at P14
(Figures 2D and S2C). In light of these findings, we further exam-
inedmyelin sheath assembly by electronmicroscopy. In contrast
to the large number of myelinated axons that are observed in
control mice at P14, myelinated axons were hardly detectable
in the optic nerve and spinal cord of Brg1cKO mutants
Figure 2. Brg1 Ablation in Oligodendrocyte Lineage Cells Leads to Myelination Defects
(A) Spinal cord at P14 was immunostained with CC1, PDGFRa, and Brg1. Boxed image is shown in the right with z axis reconstructions in side panels. Arrow
indicates Brg1 colabeling with CC1.
(B) Quantification of CC1 or PDGFRa+ cells among Brg1+ cells in the spinal white matter at P7 and P21 (n = 3 animals).
(C) Appearance of optic nerves from control (Ctrl) and Brg1cKO littermates at P14.
(D) In situ hybridization of Mbp and Plp on the spinal cord of Brg1flox/+;Olig1-Cre control (Ctrl) and Brg1flox/flox;Olig1-Cre (Brg1cKO) mice at P14.
(E) Electron micrograph analysis of optic nerves and spinal cords of Ctrl and Brg1cKO at P14.
(F and G) PDGFRa expression in spinal cords of control and mutants at P0 and P14. The density of PDGFRa+ OPCs was quantified per field (0.2 mm2) (G) (n = 3).
(H) Quantification of the average number of BrdU+ and Olig2+-colabeled cells per area (0.7 mm2) at P8 in cerebral cortices of control and mutants (n = 3).
Data are presented as mean ± SEM. Scale bars: (A) 200 mm, (D and F) 100 mm, and (E) 1 mm.
See also Figures S2 and S3.(Figure 2E), indicating a severe myelination deficit and, therefore,
a requirement for Brg1 function.
Despite the deficiency in myelin gene expression, the OPC
marker PDGFRa was detected in the spinal cord and brain of
Brg1 mutants at P7, P14, and P21, a stage before animals die(Figures 2F and S3). The number of OPCs and their proliferation
rate (percentage of bromodeoxyuridine-positive [BrdU+]-prolif-
erating OPCs) in Brg1 mutants were comparable with those of
control mice (Figures 2G and S3), suggesting that most OPCs
in Brg1 mutants are maintained. We did not detect anyCell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc. 251
Figure 3. Downregulation of Myelination-Associated Genes in Brg1 Mutants
(A) Heatmap of representative RNA-seq data of control and mutant optic nerves at P14.
(B) GO analysis depicts biological processes (blue) and cellular components (red) overrepresented in downregulated genes in Brg1 mutants.
(C) Quantitative real-time PCR analysis of myelination-associated genes in P14 control and mutant spinal cords.
(D and E) Rat OPCs were transfected with pCAG control and pCAG-Brg1(D), or Brg1-ATPase mutant (K798R) (E), and cultured without PDGF-AA for 2 days.
Expression of myelin-associated genes was determined by quantitative real-time PCR. Fold changes in (C–E) over control are derived from at least three
experiments (nR 3).
(F and H) Rat OPCs were transfected with control and Brg1-expressing vectors and cultured in the growth medium supplemented with PDGF-AA for 5 days and
then immunostained with anti-MBP (red) (F). (H) depicts the quantification of the percentage of MBP+ cells after transfection (n = 3 experiments).
(G) OPCs isolated from cortices of control andmutants at P7 by immunopanning were cultured under differentiation condition for 3 days and immunostained with
anti-MBP and anti-Olig2.
(I) Rat OPCs were treated with rat Brg1 siRNAs for 48 hr to knock down endogenous Brg1. Cells were then transfected with control vector and Brg1-expressing
vector carrying mouse Brg1, which has a mismatching sequence to rat Brg1 siRNA, for 2 days. Expression of Cnp andMbp was quantified by quantitative real-
time PCR (n = 3 experiments).
Scale bars, (F and G) 25 mm. Data were presented as mean ± SEM (*p < 0.05, * *p < 0.01, Student’s t test).
See also Figure S4 and Table S3.significant cell death in the CNS of Brg1cKO mice at these
stages based on cleaved caspase-3 immunoreactivity (data
not shown), although there was an increase of cell death when
OPCs isolated from Brg1cKO animals underwent differentiation
in vitro (Figure S4). It is possible that wemissed a narrowwindow
for cell death detection in vivo by activated caspase-3 due to
activation of microglia, which could rapidly remove dying cells.
It is worthy noting that Brg1 mutants did not exhibit significant
alterations of astrocytes, neurons, or microglia identified by
GFAP, NeuN, and Iba1, respectively, in the brain (Figure S2).
To determine the Brg1 downstream targets that regulate oligo-
dendrocyte differentiation, we carried out RNA-seq profiling
analysis using the oligodendrocyte-enriched optic nerves of
control and Brg1cKO mice at P14 (Table S3). In Brg1 mutants,252 Cell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc.Gene Ontology (GO) analysis displayed an enrichment of down-
regulated genes related to myelination and lipid-protein
synthesis (Figures 3A and 3B), consistent with deficient myelin
formation. In contrast, upregulation of differentiation inhibitors
including ID2/4, Nfia/b, Sox5, and b-catenin (Ctnnb1) was
observed (Figure 3A). Similarly, quantitative real-time PCR anal-
ysis indicated that myelination-associated genes including crit-
ical differentiation regulators such as Gm98/MRF and Sox10
were markedly downregulated (Figure 3C). Together, these
observations suggest thatBrg1 is required forOPCdifferentiation
andmyelination in theCNSbut not their proliferation and survival.
To determinewhether Brg1 is sufficient to promoteOPCdiffer-
entiation, we transfected control and Brg1-expressing vectors
into OPCs isolated from neonatal rat cortices. We found that
Figure 4. Brg1 Targets Lineage-Specific Regulators upon OPC Differentiation
(A) Heatmap of Brg1-binding signals in OPCs (left) and iOLs (right). Each line on y axis represents a genomic region ±1.5 kb flanking Brg1 summits.
(B) Venn diagram for global Brg1 occupancy in iOLs compared to OPCs.
(C) Graph depicts the conservation score of Brg1-binding summits.
(D) The distribution pattern of Brg1-binding regions in iOLs mapped to their closest Ensembl gene TSS.
(E) GO analysis of Brg1-binding regions in iOLs.
(F) Genome browser view of the distribution of Brg1 on the loci of representative myelination-related genes in iOLs (red) and OPCs (purple).
(G) Venn diagram shows minimal overlap of Brg1 occupancy between iOLs and ESCs or E11.5 forebrain, respectively.
See also Table S4.overexpression of Brg1 in cultured OPCs significantly promoted
the expression of myelin genes Mbp, Plp, and Cnp (Figure 3D).
However, the Brg1 ATPase-dead (K798R) mutant, which is
capable of forming a complex with other BAF subunits (Peterson
et al., 1994), displayed a dominant-negative function to inhibit
myelin gene expression while activating differentiation inhibitors
such as Hes1 and Id2 (Figure 3E), suggesting that ATPase
activity is critical for Brg1 function to promote myelination
programs. Furthermore, we observed that Brg1 overexpression
led to a significant increase of mature MBP+ oligodendrocytes
that harbored complex processes as compared with the control
(Figures 3F and 3H).
To investigate the differentiation capacity of OPCs in the
absence of Brg1 in vitro, we purified OPCs from control and
Brg1cKO neocortices using immunopanning. Control OPCs
readily differentiated into MBP+ mOLs. In contrast, no MBP+oligodendrocytes were detected in Brg1-deficient OPCs (Fig-
ure 3G). In addition, we found that reintroduction of Brg1 to
the Brg1-knockdown OPCs could rescue, at least partially,
for the defects in myelin gene expression (Figure 3I), suggest-
ing that Brg1 is responsible for promoting the myelination
program. Together, these observations demonstrate that acti-
vation of the Brg1 chromatin remodeler is both essential and
sufficient for initiating and promoting OPC differentiation and
maturation.
Brg1 Selectively Targets Myelination-Related Genes
during Oligodendrocyte Differentiation
To identify the direct target genes through which Brg1 regulates
the onset of oligodendrocyte differentiation, we performed the
ChIP-seq analysis for Brg1 genome-wide occupancy in OPCs
and iOLs, respectively (Figure 4A). We identified 5,465 bindingCell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc. 253
sites (fold enrichment R5; p % 109) within iOL data sets (Fig-
ure 4B; Table S4), the majority of which were present in evolu-
tionarily conserved intergenic regions or introns of the gene
loci (Figures 4C and 4D). In contrast, Brg1 occupancies in
OPCs were much fewer, and only 451 significant regions were
identified (Figure 4B). Essentially, all Brg1 peaks in OPCs colo-
calized with those identified in iOLs but at amuch-reduced inten-
sity (Figures 4A and 4B). Theweak Brg1-chromatin occupancy in
OPCs is likely due to spontaneous differentiation of a small pop-
ulation of OPCs in culture. Although Brg1 binding around tran-
scription start sites (TSSs) displays a higher binding density,
80% of Brg1-binding peaks were localized distantly from the
TSS (Figure 4D), suggesting that Brg1 mainly targets to the inter-
genic enhancer regions.
GO analysis indicated that genes overrepresented in Brg1-
binding targets were mainly related to myelination, oligodendro-
cyte differentiation, and cell-cycle arrest (Figure 4E), such as
Cnp, Cldn11, Klf9, and Zfp191 (Figure 4F). The frequency and
intensity of Brg1 binding substantially increased in iOLs over
OPCs, indicating a recruitment of the Brg1 SWI/SNF complex
to key differentiation gene loci during the initiation of OPC
differentiation.
To further determine whether Brg1-targeting regions in iOLs
are unique to oligodendrocytes, we compared Brg1 iOL-binding
sites with Brg1 targets in ESCs (Ho et al., 2009) and neural
precursors in E11.5 forebrain (Rada-Iglesias et al., 2011), respec-
tively.We observed that very few (<3%) of Brg1-occupied sites in
iOLs overlapped with those in ESCs and embryonic forebrain
(Figure 4G), suggesting that the chromatin remodeler Brg1 is re-
cruited by a lineage-specific factor(s) to occupy a specific subset
of genes that are unique for oligodendrocyte differentiation.
Brg1 Is Recruited to Oligodendrocyte Lineage-Specific
cis-Regulatory Elements Preoccupied by the
Determination Factor Olig2
De novo analysis of Brg1 occupancy revealed that Brg1 targeted
to evolutionarily conserved elements (Figure 5A). Approximately
71% Brg1-binding regions contained an enhancer box (E-box,
CANNTG) motif, which is typically recognized by bHLH tran-
scription factors (Figure 5A).
Strikingly, the most overrepresented consensusmotif of Brg1-
binding sites matches the motif targeted by the bHLH factor
Olig2 in ESCs (Figure 5A) (Mazzoni et al., 2011). Given the critical
role of Olig2 in oligodendrocyte lineage progression, we hypoth-
esized that Brg1 cooperates with Olig2 to target differentiation-
promoting genes and, hence, carried out ChIP-seq analysis to
identify Olig2-binding sites in OPCs and iOLs. Olig2 bound to
a large variety of genomic regions in OPCs, including 21,901
significant binding sites (fold enrichment R5; p % 109). The
binding sites of Olig2 in OPCs essentially persisted in differenti-
ating iOLs with 25,787 significant binding sites (Table S5). We
further detected that the majority of Brg1-binding regions in
iOLs overlapped with Olig2 signals in OPCs and iOLs, suggest-
ing that Brg1 binds to chromatin regions preoccupied by Olig2
in OPCs (Figures 5B and 5C).
Motif analysis of binding sites reveals that the majority of Olig2
and Brg1-targeted sites share essentially identical consensus
sequences carrying the E-box motif (Figure 5D). Recent studies254 Cell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc.illustrate that there are at least five evolutionarily conserved
enhancer regions (Ku¨spert et al., 2011) that regulate expression
of Sox10, an essential factor for oligodendrocyte differentiation.
Olig2 was shown to bind to the U2 enhancer in the distal 50 flank
of the Sox10 (Ku¨spert et al., 2011). Our ChIP-seq data from iOLs
demonstrated that Brg1 andOlig2 co-occupied these conserved
Sox10 enhancers containing E-box motifs in addition to the U2
region (Figure 5E). All these enhancer regions contain the
consensus Brg1/Olig2-binding motif, including the E-box (Fig-
ure 5E). In addition, the binding patterns of Olig2 and Brg1 co-
occupancy were also detected in enhancers of other key myeli-
nation-related genes, including Mbp and Ugt8a/Cgt (Figures 5F
and 5G).
To further determine whether Olig2 and Brg1 could physically
associate with each other during oligodendrocyte differentiation,
we performed coimmunoprecipitation (coIP) assays. Brg1
weakly interacted with Olig2 in OPCs (Figure 5H); however, this
interaction was dramatically enhanced when OPCs were
induced to differentiate after 24 hr treatment in differentiation
medium (Figure 5H), suggesting that Brg1 is strongly associated
with Olig2 when OPCs undergo the differentiation process. To
verify the Brg1-Olig2 interaction at the endogenous protein level,
we carried out coIP assays usingmouse brain tissues at P10 and
demonstrated that Brg1 interacted with Olig2 in vivo (Figure 5I).
Together, these observations suggest that Brg1 is an integral
component of the transcriptional control of myelination via inter-
action with Olig2 at the onset of OPC differentiation.
Distinct Genomic Distribution of Brg1 and Olig2
Targeting at Different Stages of Oligodendrocyte
Differentiation
Oligodendrocyte development involves sequential phases of
maturation, including initiation and progression of differentiation.
To investigate whether Brg1 and Olig2 exhibit temporally distinct
regulatory functions, we further performed ChIP-seq of Brg1 in
mOLs.
When comparing Brg1 genomic occupancy among OPCs,
iOLs, and mOLs, we observed dynamic changes of Brg1-target-
ing sites at each stage. These Brg1 targets can be clustered into
two categories: targets that elicit intenseBrg1 signal beginning at
either iOL or mOL stage (Figure 6A). When compared to an oligo-
dendrocyte transcriptome database (Dugas et al., 2006), genes
targeted by Brg1 in iOLs belong to a cohort of early-expressing
genes referred to as ‘‘early differentiation genes’’ (Dugas et al.,
2006), including Cnp, Mbp, Klf9, and Sirt2 (Figure 6B), whereas
those targeted byBrg1 inmOLsmainly act as ‘‘late differentiation
genes,’’ including Fnbp1, Ank3, Eml1, Tmem123, and Mylk (Du-
gas et al., 2006) (Figure 6C). Strikingly, the majority of the Brg1
target genes in mOLs were involved in cytoskeletal remodeling,
including microtubule/cytoskeleton-based transport and micro-
tubule polymerization and depolymerization (Figure 6D). Among
them, Fnbp1 and Ank3/AnkG have been shown to be critical for
membrane curvature-dependent actin polymerization and clus-
tering of voltage-gated Na channels at axon initial segments,
respectively (Takano et al., 2008; Zhou et al., 1998).
Similar dynamic changes of Olig2 target occupancy were also
observed during oligodendrocyte maturation. Despite compa-
rable target occupancy between iOLs and OPCs, Olig2 binding
Figure 5. Brg1 Recruitment to E-Box Enhancer Elements Preoccupied by Olig2
(A) De novo motif analysis of Brg1-binding regions identified a putative E-box consensus motif (CANNTG) among 71% of Brg1 ChIP-seq binding sites.
(B) Heatmap of Olig2-binding signals at OPCs (left) and iOLs (right) ±1.5 kb surrounding Brg1 iOL-binding summits.
(C) Binding profiles of Olig2 around Brg1 peak summits.
(D) Thedenovobindingmotif derived fromOlig2-binding regions. Lowerpanel showspercentageof overlappingofBrg1-bindingsites in iOLwithOlig2denovomotif.
(E) Brg1/Olig2 co-occupancy (as highlighted) of evolutionarily conserved E-box enhancers (U1–U5) in the Sox10 promoter. The E-box in Sox10 enhancers and
Brg1/Olig2-binding motif is shown in the lower panel.
(F and G) Visualization of Brg1 and Olig2-binding profiles in OPCs and iOLs on representative myelin gene loci (F, Mbp; G, Ugt8).
(H and I) Lysates from rat OPCs and iOLs (H) and P10 forebrain tissues (I) were immunoprecipitated (IP) with anti-Brg1 and IgG control and blotted by anti-Olig2.
See also Table S5.decreased inmOLs (Figure 6E).Olig2 targets inmOLsweremainly
involved in the regulation of cytoskeletal processes and organiza-
tion, particularly the Rho family of GTPases such as Cdc42 and
Rac1 (Figures 6F and S5), which are required for oligodendrocyte
maturation and the correct formationofmyelin sheaths in theCNS
(Thurnherr et al., 2006). These observations suggest that the late
differentiation genes targeted by Olig2 and Brg1 are required for
maintenance of the differentiated state and process elaboration.
Collectively, these results suggest that Brg1 and Olig2 target
distinct subsets of target genes during early and late phases of
differentiation to control oligodendrocyte lineage progression.
Brg1 and Olig2 Co-occupancy Coupled with Distinct
Histone Modifications Controls Expression of Critical
Regulators for Oligodendrocyte Differentiation
Brg1 functions primarily as a transcriptional activator containing
multiple functional domains, including a helicase ATP-bindingdomain and a bromodomain (Wu et al., 2009; Yoo and Crabtree,
2009). The latter recognizes and interacts with acetylated lysine
residues in histones to promote chromatin remodeling and gene
transcription. We hypothesized that Brg1 is recruited by Olig2
and interacts with an activating histone mark, K27 acetylation at
histone 3 (H3K27Ac), which distinguishes active enhancers from
inactive/poised enhancer elements (Creyghton et al., 2010), to
direct the transcriptionof critical genes fordifferentiation initiation.
To address the hypothesis, we performed ChIP-seq in OPCs
and iOLs with activating histone marks, H3K27Ac and H3K4me3,
which signify gene activation at enhancers and TSSs, respectively
(Martin and Zhang, 2005; Strahl and Allis, 2000), and compared
themwithBrg1andOlig2 genomic occupancy. Among the targets
that are co-occupied by Brg1/Olig2 and the respective active
histone marks, we identified a cohort of transcriptional regulators
includingpreviously identified regulatorsofoligodendrocytediffer-
entiation such as MRF, Sox10, Olig1/2, Zfp191, and Sip1/Zfhx1bCell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc. 255
Figure 6. Brg1 and Olig2 Target Distinct Transcriptional Programs at Different Stages of Oligodendrocyte Differentiation
(A) Heatmap of Brg1-binding signals at OPCs, iOLs, and mOLs ±1 kb surrounding Brg1-binding summits, showing early and late differentiation gene groups.
(B and C) Temporal expression patterns of representative Brg1-targeted genes in iOL (B) and mOL (C) were plotted against an oligodendrocyte transcriptome
database (Dugas et al., 2006) at indicated stages.
(D) GO analysis of Brg1-binding targets in mOL.
(E) Heatmap of Olig2-binding signals ±600 bp surrounding Olig2-binding summits.
(F) Genome browser visualization of Olig2 distribution on Cdc42 and Rac1 loci.
See also Figure S5, and Tables S4 and S5.(Emery, 2010; Li et al., 2009; Weng et al., 2012) (Figures 7A and
7B).MRF,whichwas downregulated inBrg1mutants (Figure 7B),
has a similar mutant phenotype to Brg1 with defects in differenti-
ation, but not OPC formation (Emery et al., 2009). We observed
that Brg1 and Olig2 were recruited to enhancer regions of MRF
designated by flanking H3K27Ac peaks (Figure 7B; Table S6).
Of particular interest, Brg1 recruitment coincidedwith a dramatic
increase in the activating H3K27Ac mark at the onset of OPC
differentiation (Figure 7B). In addition, a surge in another acti-
vating histone mark H3K4me3 (Table S7) at the promoter region
proximal to theTSSof theMRFgene locuswasobserved indiffer-
entiating OLs as compared to OPCs. This is consistent with the
activation of MRF expression upon OPC differentiation.
Based on Olig2 and Brg1 co-occupancy together with the
increase in active histone modification signatures, we identified
a cohort of potential transcriptional regulators previously unchar-
acterized in oligodendrocyte development (Figure 7A), including
oligodendrocyte-enriched transcription factors (e.g., Sall1 and
ETV6), transcription initiation factors (e.g., Med27 and TAF2),
and a cohort of histone modifiers such as histone demethylase
Kdm6b, and Cdyl, a chromodomain protein with histone acetyl-
transferase activity (Figures 7A and S6). Brg1 knockdown by
RNAi resulted in significant downregulation of these factors,256 Cell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc.including Cdyl, Kdm6b, and Sall1 (Figure 7D). Importantly, like
Brg1 knockdown, siRNA knockdown of Cdyl, Kdm6b, or Sall1
significantly inhibited myelin gene expression during OPC differ-
entiation (Figures 7E and 7F) while upregulating differentiation
inhibitors such as Hes5 (Figure 7F). The siRNA knockdown
studies also indicate that expression of these differentiation
regulators is, at least in part, mutually dependent on one another
(Figures 7D and S6).
In the promoter region of oligodendrocyte differentiation inhib-
itors suchasHes1andPDGFRa, however, levels of enrichment of
the H3K27Ac histone mark were substantially reduced in oligo-
dendrocytes as compared with OPCs, concurrent with reduced
Olig2 binding (Figures 7G and 7H). In contrast, the level of the
repressive histone mark H3K9me3 (Table S7), which is associ-
atedwithgene repression (Martin andZhang, 2005;Strahl andAl-
lis, 2000), was increased during differentiation (Figures 7G and
7H). As a control, the level of the H3K27Ac histone mark on the
promoter of the housekeeping gene b-actin was comparable
between OPCs and differentiating oligodendrocytes (Figure 7I).
These data suggest that Olig2 and Brg1 targeting coupled with
the transcriptionally linked epigenetic landscape establishes
the gene transcription program to promote oligodendrocyte
differentiation.
Figure 7. Brg1 and Olig2 Co-occupancy Coupled with Epigenetic Marks to Modulate Expression of Key Oligodendrocyte Differentiation
Regulatory Genes
(A) Representative targeting genes associated with transcriptional regulation predicted by Brg1/Olig2 co-occupancy and active histone marks.
(B and C) Genome browser view of genetic and epigenetic landscape surrounding the MRF (B) or Cdyl (C) gene locus. Upper panel is an RNA-seq peak visu-
alization of gene expression from Ctrl and mutants. Lower panel shows ChIP-seq with indicated antibodies in rat OPCs and iOLs.
(D) Rat OPCs were treated with scrambled control and Brg1 siRNA for 48 hr. Gene expression was examined by quantitative real-time PCR.
(E) Efficiency of Brg1, Cdyl, Kdm6b, and Sall1 knockdown in OPCs was examined by quantitative real-time PCR.
(F) Expression of Mbp, Cnp, Plp, and Hes5 was measured in OPCs with Brg1, Cdyl, Kdm6b, or Sall1 siRNA knockdown as indicated.
(G–I) Genome browser visualization of H3K27Ac, H3K9me3, Olig2, or Brg1-targeting sites on the gene loci of differentiation inhibitors Hes1 (G), PDGFRa (H), and
b-actin (Actb) (I) during OPC differentiation.
Fold changes in (D–F) over control are derived from three experiments (n = 3). All the data are presented as mean ± SEM. *p < 0.01, * *p < 0.001; Student’s t test
(D and E); one-way ANOVA (F).
See also Figures S6 and S7, and Tables S6 and S7.DISCUSSION
Our genome-wide, base-resolution time course of chromatin
and transcriptome changes sheds light on the molecular basis
of oligodendrocyte development. In this study, we uncover thatactivation of a Brg1-based ATP-dependent SWI/SNF chromatin
remodeler is sufficient for initiating transcriptional programs to
establish oligodendrocyte identity. Importantly, we find that
the oligodendrocyte-lineage determination factor Olig2 tran-
scriptionally prepatterns the chromatin-remodeling factorCell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc. 257
Smarca4/Brg1 to the enhancer elements to control oligo-
dendrocyte differentiation. The identification of stage-specific
enhancers at the genome-wide level unveils a series of regula-
tory factors that control oligodendrocyte development. Our
genome-wide multistage study further reveals a mechanism of
oligodendrocyte differentiation by linking the transcription factor
control with stage- and target-specific epigenetic regulation and
chromatin remodeling; such mechanistic insight has not been
previously defined for CNSmyelination. Thus, our results provide
a genome-wide map of transcriptional and epigenetic changes
that defines stepwise oligodendrocyte lineage progression, an
instructive reference to gene regulatory networks and epige-
nomics, and important elements and principles for defining the
complex process of myelination in the vertebrate CNS.
Activation of ATP-Dependent Brg1 Chromatin-
Remodeling Complex Drives Oligodendrocyte Lineage
Progression
The Brg1 chromatin remodeler was originally thought to be
a ubiquitously expressed factor; however, unexpectedly, we
find that Brg1, but not Brm1, is strongly transcribed and upregu-
lated at the onset of differentiation during oligodendrocyte
lineage progression. Brg1 upregulation and activation have not
been reported in other cellular processes such as during the tran-
sition from ESCs to embryonic fibroblasts, activation of neuronal
cells, or estrogen response in human breast cancer cells (Fig-
ure S1), suggesting that activation of Brg1 may be specific for
promoting the temporal transition of oligodendrocyte precursor
differentiation. What dictates the upregulation of Brg1 from
OPC to iOL transition remains unknown at present. Our ChIP-
seq data indicate that genomic occupancy by Olig2 precedes
that of Brg1 during oligodendrocyte lineage progression. Olig2
targets the locus of Brg1 in OPCs, but not vice versa (Figure S1).
In addition, Brg1 is downregulated in the oligodendrocyte-
enriched corpus callosum of Olig2-ablated mutants (Figure S1),
suggesting thatOlig2might have a role in regulatingBrg1 expres-
sion. Alternatively, it is possible that regulatory miRNAs such as
miR-219andmiR-338 (Dugaset al., 2010; Zhaoet al., 2010)might
control Brg1 expression during the OPC transition.
Our data suggest that Brg1 regulates the OPC-to-oligoden-
drocyte transition in a stage-specific manner. Deletion of Brg1
by Olig1-Cre does not appear to affect the developmental tran-
sition from Olig+ pMN progenitors to form OPCs at embryonic
stages (Figure S3C), despite blocking the transition from OPCs
into oligodendrocytes. In addition, inhibition of Brg1 does not
cause global downregulation in gene expression programs
because downregulation of Brg1 in vivo and in vitro inhibits
differentiation activators while activating differentiation inhibitors
(Figures 3A and 3E). Furthermore, Brg1 targets are significantly
overrepresented by factors that are required for oligodendrocyte
differentiation. These observations suggest a specific function of
Brg1 during the transition from OPCs to oligodendrocytes.
Olig2 Directs the Functional Specificity of the
Brg1-Dependent Chromatin-Remodeling Complex
to Establish Oligodendrocyte Identity
Our studies uncover Olig2 as a prepatterning factor that directs
the recruitment of Brg1 to oligodendrocyte lineage-specific cis-258 Cell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc.regulatory elements during the critical transition from OPCs to
iOLs. The regulation of the functional specificity and activity of
the chromatin remodeler Brg1 by Olig2, coupled with distinct
epigenetic changes during developmental transition, likely plays
a key role in the activation of the stage-specific transcriptional
program for oligodendrocyte development. These studies
provide important insights into the molecular mechanism by
which Olig2, a factor long known to be involved in oligodendro-
cyte lineage, acts to regulate the development of this lineage.
Once considered to be general mediators of transcription, the
Brg1-based SWI/SNF chromatin-remodeling complexes are
increasingly recognized for their cell-type- or tissue-specific
functions during development (Euskirchen et al., 2011; Yoo
and Crabtree, 2009). Much of this specificity is thought to stem
from posttranslational modification of SWI-SNF subunits and/
or variations in subunit composition such as neuronal-specific
BAF complex (nBAF) (Lessard et al., 2007; Wu et al., 2007). We
observed that Brg1-binding targets in oligodendrocyte lineage
cells are specifically associated with the differentiation program
for oligodendrocytes, but not ESCs or neural progenitors.
However, whether there exists an oligodendrocyte-specific
BAF complex with unique subunit composition and what
controls the functional specificity of the Brg1 chromatin-remod-
eling complex for targeting oligodendrocyte-specific genes
remain unresolved at present.
Upregulation of Brg1 complex components, together with
a surge of physical association of Olig2 with the Brg1 complex
at the onset of OPC differentiation, suggests that Olig2 can
functionally prepattern Brg1 complex targeting on oligodendro-
cyte-specific enhancers and therefore directs Brg1 chromatin-
remodeling activity specifically to activate the oligodendrocyte
differentiation program. This is in contrast to neuronal cells
wherein a change in Brg1 complex composition acts as a devel-
opmental switch in the nervous system (Wu et al., 2009; Yoo and
Crabtree, 2009). Given the essential role of Olig2 in neural
subtype switch (Li et al., 2011; Zhu et al., 2012), regulation of
the functional specificity and activity of chromatin-remodeling
complexes by Olig2 should have important implications on the
molecular mechanisms of neural subtype specification and
lineage development.
Temporal Control of Oligodendrocyte Lineage
Progression by Dynamic Distribution of Brg1/Olig2
Targeting
Our genome-wide targeting studies at multiple developmental
stages uncover a temporally regulated mechanism of Brg1 and
Olig2 targeting in controlling stage-specific transcriptional
programs for oligodendrocyte lineage initiation and maturation.
At the onset of oligodendrocyte differentiation, Brg1 and Olig2
bind preferentially to the enhancers of differentiation-promoting
genes. Bromodomain-containing Brg1 recruited by Olig2 may
recognize activated histone acetylation marks such as
H3K27Ac to promote expression of key differentiation activators
such as MRF and Sox10.
Interestingly, upon oligodendrocyte maturation, accessibility
of Brg1 and Olig2 in genomic loci is reduced, and Brg1 and
Olig2 appear to redistribute to distinct target sites, whereas
expression of myelin genes continues to increase. This suggests
that Olig2-engaged Brg1 chromatin-remodeling complex would
be required transiently during the initial period of OPC differenti-
ation to reset histones for activating a gene expression program
and that it would be sustained by histone marks or epigenetic
memory. Strikingly, in maturating oligodendrocytes, despite
the reduction of target gene-binding sites, Brg1 and Olig2
binding redistributes to a set of genes critical for cytoskeleton
reorganization and curvature-dependent actin polymerization,
which are required for complex morphogenesis during myelina-
tion. These data suggest a stage-specific switch of Brg1/Olig2
targeting in the regulation of distinct sets of genes from initiating
the differentiation process to maintaining the differentiation state
during lineage progression. The mechanisms underlying the
temporal specificity of Olig2/Brg1 targeting are not known at
present. It is possible that stage-specific regulators (e.g., MRF
and Sox10) activated by Olig2/Brg1 targeting at the differentia-
tion onset could form a positive feedback loop to interact with
Olig2 and/or Brg1, as suggested in other contexts (Liu et al.,
2007; Weider et al., 2012), to control their targeting specificity
at later stages of differentiation and maturation. Therefore, the
coordination of Brg1/Olig2 functional dynamics at different
stages is an integral component in the spatial and temporal
control of oligodendrocyte development.
Our Brg1/Olig2-targeting studies in conjunction with epige-
netic histone modification analysis also shed light on stage-
specific oligodendrocyte cis-regulatory elements at a genome-
wide level. Temporally specific Olig2 and Brg1 co-occupancy
identifies and predicts cis-regulatory enhancer elements that
are critical for differentiation initiation and maintenance during
the myelination process. The identification of cis-regulatory
elements activated de novo during the transition of OPCdifferen-
tiation uncovers a cohort of oligodendrocyte-enriched transcrip-
tion factors, chromatinmodifiers, and signaling regulators, which
will yield important clues to the regulation of the myelination
process and undoubtedly illuminate a landscape of therapeutic
targets for promoting myelin repair in the CNS. The roles of the
candidate cis-regulatory elements and their rules in engaging
gene regulation should be greatly clarified by future analysis, to
detect specific chromatin looping events, enhancer activation
states, e.g., mapped by association with p300 and HDACs,
and DNA methylation. It is noteworthy that Brg1 expression is
substantially upregulated in oligodendrocyte lineage cells in
lysolecithin-induced demyelinating lesion during remyelination
(Figure S7), suggesting a potentially important function of Brg1
in oligodendrocyte remyelination. Given the critical role of Brg1
in promoting oligodendrocyte differentiation, augmenting the
activity of the ATP-dependent chromatin-remodeling enzyme
might have therapeutic benefits for promoting myelin repair in
demyelinating diseases.
EXPERIMENTAL PROCEDURES
Generation of Brg1 Conditional Knockout Mice and Histology
Brg1lox/lox mice (Sumi-Ichinose et al., 1997) were crossed with Olig1-Cremice
to generate Brg1cKO (Brg1lox/lox;Olig1Cre+/) and heterozygous control
(Olig1Cre+/; Brg1lox/+) mice. All animal use and studies were approved by
ethical committees at Sichuan University, China, and by the Institutional
Animal Care and Use Committee of the University of Texas Southwestern
Medical Center at Dallas, USA. For BrdU incorporation analysis, control andBrg1cKO littermates were injected with BrdU (Sigma-Aldrich, St. Louis)
(100 mg/kg body weight) 3 hr prior to sacrifice. See Extended Experimental
Procedures for the detailed histology and list of antibodies used.
Oligodendrocyte Culture, Transfection, and CoIP
Primary rat OPCs were isolated from cortices of pups at P2 using a differential
detachment procedure as previously described (Chen et al., 2007). Briefly,
mixed glial cells were cultured in 15% FBS medium for 5–7 days, then
switched to B104 conditional medium for 2 days prior to isolating OPCs by
mechanical dissociation in an orbital shaker. Isolated rat OPCs were collected
or grown in the OPC growth medium (Sato medium supplemented with mito-
gens 10 ng/ml PDGF-AA and 20 ng/ml bFGF) and differentiated in oligoden-
drocyte differentiation medium (Sato medium supplemented with 15 nM
thyroid hormone T3 and 10 ng/ml ciliary neurotrophic factor). Mouse OPCs
were isolated from P7–P8 cortices of control and Brg1cKO mutants by immu-
nopanning with antibodies Ran-2, GalC, and PDGFRa sequentially as previ-
ously described (Chan et al., 2004). siRNAs for Brg1, Cdyl, Kdm6b, and
Sall1 were purchased from Sigma-Aldrich. Rat OPCs were transfected with
expression vectors or siRNAs by using Amaxa Nucleofector (Lonza) according
to manufacturer’s protocol. pCAG-Brg1 and lenti-Brg1 expression vectors are
the gift of Dr. Jiang Wu. CoIP and immunoblotting were performed as
described previously by Weng et al. (2012). Briefly, a total of 300 mg of protein
lysates from cells or brain tissues was precleaned using protein A-Sepharose
and then immunoprecipitated with 2 mg antibody for coIP.
ChIP-Seq
ChIP assays were performed as previously described with minor modifications
(Flavell et al., 2008; Weng et al., 2012). Briefly, OPCs and oligodendrocytes at
different stages (20 million cells) were fixed for 10 min at room temperature
with 1% formaldehyde-containing medium. Nuclei were pelleted and soni-
cated in sonication buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA, 0.5 mM
EGTA, and protease inhibitor cocktail). Sonicated chromatin (300 mg) was
used for immunoprecipitation by incubation with appropriate antibodies
(4 mg) overnight at 4C. Ten percent of chromatin used for each ChIP reaction
was kept as input DNA. Prerinsed protein A/G plus agarose beads (50 ml) was
added to each ChIP reaction and incubated for 1 hr at 4C. The beads were
then incubated in 200 ml elution buffer at 65C for 20 min to elute immunopre-
cipitated materials. The ChIP-seq libraries were prepared using 5500 SOLiD
Fragment Library Core Kit (PN 4464412) and then run on the 5500xl SOLiD
sequencer from Life Technologies. See Extended Experimental Procedures
for a list of antibodies used.
ChIP-Seq Peak-Calling and Data Analysis
All sequencing data were mapped to November 2004 rat genome assembly
(Baylor 3.4/rn4), and peak calling was performed using MACS (Model-based
Analysis of ChIP-seq) version 1.4.2 (http://liulab.dfci.harvard.edu/MACS)
with default parameters to get primary binding regions. These primary regions
were further filtered using the following criteria to define a more stringent
protein-DNA interactome: (1) the p value cutoff was set to <109; (2) an enrich-
ment of 5-fold; and (3) tag number >20. For ChIP-seq analysis of RNAPII tar-
geting, the primary regions were filtered with the criteria of (1) an enrichment
of 3.5-fold, (2) tag number >25, and (3) subtract with background regions.
RNA-Seq and Data Analysis
RNA-seq libraries were prepared using Illumina RNA-Seq Preparation Kit and
sequenced by HiSeq 2000 sequencer. RNA-seq reads were mapped using
TopHat with default settings (http://tophat.cbcb.umd.edu). TopHat output
data were then analyzed by Cufflinks to (1) calculate FPKM values for known
transcripts in mouse genome reference, and (2) test the changes of gene
expression between Brg1cKO and control. Heatmap of gene differential
expression was generated using R language (http://www.r-project.org).
Statistical Analysis
Unbiased statistical comparison between the ChIP-seq and microarray data
sets was performed by culling a random sample using a sampling software
SPSS version 8.0 (http://spss.en.softonic.com). The significance of theCell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc. 259
coefficients among the common target genes between these data sets was
tested with a binomial distribution test.
Quantifications were performed from at least three different experimental
groups, and results were presented as mean ± SEM. Student’s two-tailed t
test was used to compare two sets of data. Multiple comparisons were
analyzed using one-way ANOVA followed by a Tukey’s post hoc test. p Value
<0.05 is considered to be statistically significant.
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Sequencing data have been deposited to GEO with accession number
GSE42454.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and seven tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2012.12.006.
ACKNOWLEDGMENTS
The authors would like to thank TomHu, Nana Li, Shujun Bai, Akiko Nishiyama,
Huashun Li, Vanessa Schmid, and Sara Hildebrand for experimental support.
We thank Drs. Lee Kraus, Charles Stiles, John Svaren, Jianrong Li, and EdHur-
lock for critical comments and suggestions. This study was funded in part by
grants from the US National Institutes of Health (R01NS072427 and
R01NS075243) and the National Multiple Sclerosis Society (RG4568) to
Q.R.L., and National Science Foundation of China (NSFC: 81270757) to
M.M., and program for Changjiang scholars and innovative research team in
University (IRT0935).
Received: May 24, 2012
Revised: August 22, 2012
Accepted: November 8, 2012
Published: January 17, 2013
REFERENCES
Adelman, K., and Lis, J.T. (2012). Promoter-proximal pausing of RNA poly-
merase II: emerging roles in metazoans. Nat. Rev. Genet. 13, 720–731.
Becker, P.B., and Ho¨rz, W. (2002). ATP-dependent nucleosome remodeling.
Annu. Rev. Biochem. 71, 247–273.
Berger, J., Moser, H.W., and Forss-Petter, S. (2001). Leukodystrophies: recent
developments in genetics, molecular biology, pathogenesis and treatment.
Curr. Opin. Neurol. 14, 305–312.
Chan, J.R., Watkins, T.A., Cosgaya, J.M., Zhang, C., Chen, L., Reichardt, L.F.,
Shooter, E.M., and Barres, B.A. (2004). NGF controls axonal receptivity to
myelination by Schwann cells or oligodendrocytes. Neuron 43, 183–191.
Chang, A., Tourtellotte, W.W., Rudick, R., and Trapp, B.D. (2002). Premyelinat-
ing oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med.
346, 165–173.
Chen, Y., Balasubramaniyan, V., Peng, J., Hurlock, E.C., Tallquist, M., Li, J.,
and Lu, Q.R. (2007). Isolation and culture of rat and mouse oligodendrocyte
precursor cells. Nat. Protoc. 2, 1044–1051.
Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W.,
Steine, E.J., Hanna, J., Lodato, M.A., Frampton, G.M., Sharp, P.A., et al.
(2010). Histone H3K27ac separates active from poised enhancers and
predicts developmental state. Proc. Natl. Acad. Sci. USA 107, 21931–21936.
Dugas, J.C., Tai, Y.C., Speed, T.P., Ngai, J., and Barres, B.A. (2006). Func-
tional genomic analysis of oligodendrocyte differentiation. J. Neurosci. 26,
10967–10983.
Dugas, J.C., Cuellar, T.L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zama-
nian, J.L., Foo, L.C., McManus, M.T., and Barres, B.A. (2010). Dicer1 and miR-
219 Are required for normal oligodendrocyte differentiation and myelination.
Neuron 65, 597–611.260 Cell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc.Emery, B. (2010). Regulation of oligodendrocyte differentiation and myelina-
tion. Science 330, 779–782.
Emery, B., Agalliu, D., Cahoy, J.D., Watkins, T.A., Dugas, J.C., Mulinyawe,
S.B., Ibrahim, A., Ligon, K.L., Rowitch, D.H., and Barres, B.A. (2009). Myelin
gene regulatory factor is a critical transcriptional regulator required for CNS
myelination. Cell 138, 172–185.
Euskirchen, G.M., Auerbach, R.K., Davidov, E., Gianoulis, T.A., Zhong, G., Ro-
zowsky, J., Bhardwaj, N., Gerstein, M.B., and Snyder, M. (2011). Diverse roles
and interactions of the SWI/SNF chromatin remodeling complex revealed
using global approaches. PLoS Genet. 7, e1002008.
Flavell, S.W., Kim, T.K., Gray, J.M., Harmin, D.A., Hemberg, M., Hong, E.J.,
Markenscoff-Papadimitriou, E., Bear, D.M., and Greenberg, M.E. (2008).
Genome-wide analysis of MEF2 transcriptional program reveals synaptic
target genes and neuronal activity-dependent polyadenylation site selection.
Neuron 60, 1022–1038.
Franklin, R.J., and Ffrench-Constant, C. (2008). Remyelination in the CNS:
from biology to therapy. Nat. Rev. Neurosci. 9, 839–855.
Haberland, M., Montgomery, R.L., and Olson, E.N. (2009). The many roles of
histone deacetylases in development and physiology: implications for disease
and therapy. Nat. Rev. Genet. 10, 32–42.
Hah, N., Danko, C.G., Core, L., Waterfall, J.J., Siepel, A., Lis, J.T., and Kraus,
W.L. (2011). A rapid, extensive, and transient transcriptional response to
estrogen signaling in breast cancer cells. Cell 145, 622–634.
Ho, L., Jothi, R., Ronan, J.L., Cui, K., Zhao, K., and Crabtree, G.R. (2009). An
embryonic stem cell chromatin remodeling complex, esBAF, is an essential
component of the core pluripotency transcriptional network. Proc. Natl.
Acad. Sci. USA 106, 5187–5191.
Jenuwein, T., and Allis, C.D. (2001). Translating the histone code. Science 293,
1074–1080.
Kim, T.K., Hemberg, M., Gray, J.M., Costa, A.M., Bear, D.M., Wu, J., Harmin,
D.A., Laptewicz, M., Barbara-Haley, K., Kuersten, S., et al. (2010). Widespread
transcription at neuronal activity-regulated enhancers. Nature 465, 182–187.
Ku¨spert, M., Hammer, A., Bo¨sl, M.R., and Wegner, M. (2011). Olig2 regulates
Sox10 expression in oligodendrocyte precursors through an evolutionary
conserved distal enhancer. Nucleic Acids Res. 39, 1280–1293.
Lessard, J., Wu, J.I., Ranish, J.A., Wan, M., Winslow, M.M., Staahl, B.T., Wu,
H., Aebersold, R., Graef, I.A., and Crabtree, G.R. (2007). An essential switch in
subunit composition of a chromatin remodeling complex during neural devel-
opment. Neuron 55, 201–215.
Li, H., He, Y., Richardson, W.D., and Casaccia, P. (2009). Two-tier transcrip-
tional control of oligodendrocyte differentiation. Curr. Opin. Neurobiol. 19,
479–485.
Li, H., de Faria, J.P., Andrew, P., Nitarska, J., and Richardson, W.D. (2011).
Phosphorylation regulates OLIG2 cofactor choice and themotor neuron-oligo-
dendrocyte fate switch. Neuron 69, 918–929.
Liu, Z., Hu, X., Cai, J., Liu, B., Peng, X., Wegner, M., and Qiu, M. (2007). Induc-
tion of oligodendrocyte differentiation by Olig2 and Sox10: evidence for
reciprocal interactions and dosage-dependent mechanisms. Dev. Biol. 302,
683–693.
Lu, Q.R., Sun, T., Zhu, Z., Ma, N., Garcia, M., Stiles, C.D., and Rowitch, D.H.
(2002). Common developmental requirement for Olig function indicates
a motor neuron/oligodendrocyte connection. Cell 109, 75–86.
Martin, C., and Zhang, Y. (2005). The diverse functions of histone lysine meth-
ylation. Nat. Rev. Mol. Cell Biol. 6, 838–849.
Mazzoni, E.O., Mahony, S., Iacovino, M., Morrison, C.A., Mountoufaris, G.,
Closser, M., Whyte, W.A., Young, R.A., Kyba, M., Gifford, D.K., and Wichterle,
H. (2011). Embryonic stem cell-based mapping of developmental transcrip-
tional programs. Nat. Methods 8, 1056–1058.
Min, I.M., Waterfall, J.J., Core, L.J., Munroe, R.J., Schimenti, J., and Lis, J.T.
(2011). Regulating RNA polymerase pausing and transcription elongation in
embryonic stem cells. Genes Dev. 25, 742–754.
Nielsen, J.A., Hudson, L.D., and Armstrong, R.C. (2002). Nuclear organization
in differentiating oligodendrocytes. J. Cell Sci. 115, 4071–4079.
Peterson, C.L., Dingwall, A., and Scott, M.P. (1994). Five SWI/SNF gene prod-
ucts are components of a large multisubunit complex required for transcrip-
tional enhancement. Proc. Natl. Acad. Sci. USA 91, 2905–2908.
Pfeiffer, S.E., Warrington, A.E., andBansal, R. (1993). The oligodendrocyte and
its many cellular processes. Trends Cell Biol. 3, 191–197.
Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A., and Wy-
socka, J. (2011). A unique chromatin signature uncovers early developmental
enhancers in humans. Nature 470, 279–283.
Strahl, B.D., and Allis, C.D. (2000). The language of covalent histone modifica-
tions. Nature 403, 41–45.
Sumi-Ichinose, C., Ichinose, H., Metzger, D., and Chambon, P. (1997).
SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carci-
noma cells. Mol. Cell. Biol. 17, 5976–5986.
Takano, K., Toyooka, K., and Suetsugu, S. (2008). EFC/F-BARproteins and the
N-WASP-WIP complex induce membrane curvature-dependent actin poly-
merization. EMBO J. 27, 2817–2828.
Thurnherr, T., Benninger, Y., Wu, X., Chrostek, A., Krause, S.M., Nave, K.A.,
Franklin, R.J., Brakebusch, C., Suter, U., and Relvas, J.B. (2006). Cdc42 and
Rac1 signaling are both required for and act synergistically in the correct
formation of myelin sheaths in the CNS. J. Neurosci. 26, 10110–10119.
Trapp, B.D., Peterson, J., Ransohoff, R.M., Rudick, R., Mo¨rk, S., and Bo¨, L.
(1998). Axonal transection in the lesions of multiple sclerosis. N. Engl. J.
Med. 338, 278–285.
Weider, M., Ku¨spert, M., Bischof, M., Vogl, M.R., Hornig, J., Loy, K., Kosian, T.,
Mu¨ller, J., Hillga¨rtner, S., Tamm, E.R., et al. (2012). Chromatin-remodeling
factor Brg1 is required for Schwann cell differentiation and myelination. Dev.
Cell 23, 193–201.
Weng, Q., Chen, Y., Wang, H., Xu, X., Yang, B., He, Q., Shou, W., Chen, Y., Hi-
gashi, Y., van den Berghe, V., et al. (2012). Dual-mode modulation of Smad
signaling by Smad-interacting protein Sip1 is required for myelination in the
central nervous system. Neuron 73, 713–728.Wu, J.I., Lessard, J., Olave, I.A., Qiu, Z., Ghosh, A., Graef, I.A., and Crabtree,
G.R. (2007). Regulation of dendritic development by neuron-specific chro-
matin remodeling complexes. Neuron 56, 94–108.
Wu, J.I., Lessard, J., and Crabtree, G.R. (2009). Understanding the words of
chromatin regulation. Cell 136, 200–206.
Xin, M., Yue, T., Ma, Z., Wu, F.F., Gow, A., and Lu, Q.R. (2005). Myelinogenesis
and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-
null mice. J. Neurosci. 25, 1354–1365.
Ye, F., Chen, Y., Hoang, T., Montgomery, R.L., Zhao, X.H., Bu, H., Hu, T.,
Taketo, M.M., van Es, J.H., Clevers, H., et al. (2009). HDAC1 and HDAC2 regu-
late oligodendrocyte differentiation by disrupting the beta-catenin-TCF inter-
action. Nat. Neurosci. 12, 829–838.
Yoo, A.S., and Crabtree, G.R. (2009). ATP-dependent chromatin remodeling in
neural development. Curr. Opin. Neurobiol. 19, 120–126.
Yue, T., Xian, K., Hurlock, E., Xin, M., Kernie, S.G., Parada, L.F., and Lu, Q.R.
(2006). A critical role for dorsal progenitors in cortical myelination. J. Neurosci.
26, 1275–1280.
Zhao, X., He, X., Han, X., Yu, Y., Ye, F., Chen, Y., Hoang, T., Xu, X., Mi, Q.S.,
Xin, M., et al. (2010). MicroRNA-mediated control of oligodendrocyte differen-
tiation. Neuron 65, 612–626.
Zhou, D., Lambert, S., Malen, P.L., Carpenter, S., Boland, L.M., and Bennett,
V. (1998). AnkyrinG is required for clustering of voltage-gated Na channels at
axon initial segments and for normal action potential firing. J. Cell Biol. 143,
1295–1304.
Zhou, Q., and Anderson, D.J. (2002). The bHLH transcription factors OLIG2
and OLIG1 couple neuronal and glial subtype specification. Cell 109, 61–73.
Zhu, X., Zuo, H., Maher, B.J., Serwanski, D.R., LoTurco, J.J., Lu, Q.R., and
Nishiyama, A. (2012). Olig2-dependent developmental fate switch of NG2
cells. Development 139, 2299–2307.Cell 152, 248–261, January 17, 2013 ª2013 Elsevier Inc. 261
